BIOMOTUM, LLC

PORTLAND, OR · Founded 2019 · Medtech · Private

Robotic exoskeletons that provide assistance and resistance for rehabilitation

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · biomotum.com

Sector: Medtech
Headquarters: PORTLAND, OR
Founded: 2019
Latest Form D: $200K, Mar 2022
Total capital: $3M

Federal grants: $2.2M; 4 awards · 2020–2023; Rank in peer group#511 of 538
Private capital raised: $780K; 2 Form D · last Mar 2022; 55 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Jul 2023Federal grantHealth and Human S · Phase I · An adjustable stiffness orthosis to maintain muscle engagement and push-off power in cerebral palsy.$274K
Aug 2022Federal grantHealth and Human S · Phase II · Development of a robotic ankle assist device to improve mobility in individuals with movement disorders.$772K
Mar 2022Private capital raisedForm D · SEC · 2nd filing$200K
Aug 2021Federal grantHealth and Human S · Phase II · Development of a robotic ankle assist device to improve mobility in individuals with movement disorders.$885K
Nov 2020Private capital raisedForm D · SEC · 1st filing$580K
Sep 2020Federal grantHealth and Human S · Phase II · Development of a robotic ankle assist device to improve mobility in individuals with movement disorders.$298K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

2months

from BIOMOTUM, LLC’s first federal award to its first private round.

First federal award · Sep 2020: Health and Human S · $298K
First Form D · Nov 2020: $580K · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Raymond C. BrowningExecutive Officer, DirectorNamed in SEC Form D filings
Zachary L. LernerExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

OPTOFLUIDICS, INC.Similar federal contract value in Medtech · null in contracts
MERU BIOTECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
B2M MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
Translational Imaging Innovations, Inc.Similar federal contract value in Medtech · null in contracts
Ananya Health IncSimilar federal contract value in Medtech · null in contracts
Berman Medical, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.